The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr chr7
start 27184518
end 27189293
lncRNA name HOXA11-AS
entrez id 221883
hgnc id HGNC:24957
ensg id ENSG00000240990
refseq id NR_002795
methods qPCR etc.
regulated up-regulated
function description The data revealed that the relative transcript level of HOXA11-AS was upregulated in vivo and in vitro in models of breast cancer. Knockdown of HOXA11-AS in MDA-MB-231 and MDA-MB-436 breast cancer cell lines inhibited the formation of cell colonies and arrested the cell cycle at the G0/G1 phase. Depletion of HOXA11-AS using two specific short interfering (si)RNAs against HOXA11-AS (siHOXA11-AS-1 and siHOXA11-AS-2) additionally suppressed the cell proliferative rate. Furthermore, transwell assays and wound-healing analysis revealed that siRNA transfection inhibited cell migration and invasion by ~50% in the two cell lines. The results of the present study demonstrated the oncogenic role of HOXA11-AS in breast cancer, providing novel clues for the future clinical diagnosis and treatment of early stage breast cancer patients.
pubmed id 28791375
year 2017
title Long non-coding RNA HOXA11-AS promotes cell proliferation and metastasis in human breast cancer
drug X
circulating X
survival X

CopyRight © University of Miami, USA; Harbin Medical University, China